{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:15:50Z","timestamp":1789992950641,"version":"4.0.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cytomegalovirus (CMV)-specific CD8\u2005+\u2005T-cell responses can be detected early in fetal life, but their role in the manifestations of congenital CMV (cCMV) infection remains largely unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>CMV-specific CD8\u2005+\u2005T-cell responses were assessed in neonates with cCMV using QuantiFERON\u00ae-CMV assay, within day 14 of life (T0) and during the second month of life (T1). Detection and quantification of CMV DNA in whole blood and urine samples were performed at both time points. QuantiFERON\u00ae-CMV results were evaluated in relation to timing of maternal infection, clinical manifestations of cCMV and CMV DNA levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Thirty neonates were enrolled (10\/30 [33%] symptomatic; 20\/30 [67%] asymptomatic). At T0 16\/30 (53%) subjects had a reactive QuantiFERON\u00ae-CMV result and 16\/16 (100%) were asymptomatic, whereas 14\/30 (47%) had a nonreactive or indeterminate QuantiFERON\u00ae-CMV result and 4\/14 (29%) were asymptomatic. At T1, 17\/29 (59%) subjects had a reactive QuantiFERON\u00ae-CMV result, and 17\/17 (100%) were asymptomatic, whereas 12\/29 (41%) had a nonreactive or indeterminate result and 3\/12 (25%) were asymptomatic. At both T0 and T1 reactive QuantiFERON\u00ae-CMV results correlated with lack of symptoms (P\u2005=\u2005.0001). At T1 median CMV DNAemia was lower in subjects with reactive QuantiFERON\u00ae-CMV results as compared with subjects with nonreactive or indeterminate results (1.82 log IU\/mL [1.82\u20132.89] vs 2.55 log IU\/mL [1.82\u20134.42], P\u2005=\u2005.009). No correlation was found between QuantiFERON\u00ae-CMV results and gestational age at maternal infection nor with urine CMV DNA levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A detectable CMV-specific CD8\u2005+\u2005T-cell response, evaluated using the QuantiFERON\u00ae-CMV assay, correlates with the lack of CMV-related symptoms and the control of CMV DNAemia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaa704","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T19:15:42Z","timestamp":1591038942000},"page":"367-373","source":"Crossref","is-referenced-by-count":15,"title":["Immune Monitoring Using QuantiFERON\u00ae-CMV Assay in Congenital Cytomegalovirus Infection: Correlation With Clinical Presentation and CMV DNA Load"],"prefix":"10.1093","volume":"73","author":[{"given":"Maria Grazia","family":"Capretti","sequence":"first","affiliation":[{"name":"Neonatal Unit, Department of Medical and Surgical Sciences, St.Orsola Polyclinic, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5258-9417","authenticated-orcid":false,"given":"Concetta","family":"Marsico","sequence":"additional","affiliation":[{"name":"Neonatal Unit, Department of Medical and Surgical Sciences, St.Orsola Polyclinic, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Chiereghin","sequence":"additional","affiliation":[{"name":"Operative Unit of Clinical Microbiology, Department of Specialized, Experimental and Diagnostic Medicine, St.Orsola Polyclinic, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Gabrielli","sequence":"additional","affiliation":[{"name":"Operative Unit of Clinical Microbiology, St.Orsola Polyclinic, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Aceti","sequence":"additional","affiliation":[{"name":"Neonatal Unit, Department of Medical and Surgical Sciences, St.Orsola Polyclinic, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Lazzarotto","sequence":"additional","affiliation":[{"name":"Operative Unit of Clinical Microbiology, Department of Specialized, Experimental and Diagnostic Medicine, St.Orsola Polyclinic, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"2021080205101042300_CIT0001","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"key":"2021080205101042300_CIT0002","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"key":"2021080205101042300_CIT0003","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2011.07.005","article-title":"Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age","volume":"52","author":"Enders","year":"2011","journal-title":"J Clin Virol"},{"key":"2021080205101042300_CIT0004","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jcv.2005.09.015","article-title":"Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome","volume":"35","author":"Pass","year":"2006","journal-title":"J Clin Virol"},{"key":"2021080205101042300_CIT0005","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/cid\/ciy1128","article-title":"Sequelae of congenital cytomegalovirus following maternal primary infections are limited to those acquired in the first trimester of pregnancy","volume":"69","author":"Faure-Bardon","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021080205101042300_CIT0006","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cis818","article-title":"State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician","volume":"55","author":"Egli","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021080205101042300_CIT0007","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2021080205101042300_CIT0008","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/TP.0b013e31823c1cd4","article-title":"Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia","volume":"93","author":"Lisboa","year":"2012","journal-title":"Transplantation"},{"key":"2021080205101042300_CIT0009","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1399-3062.2006.00199.x","article-title":"Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV","volume":"9","author":"Walker","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"2021080205101042300_CIT0010","doi-asserted-by":"crossref","first-page":"e74744","DOI":"10.1371\/journal.pone.0074744","article-title":"Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV\u00ae assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications","volume":"8","author":"Tey","year":"2013","journal-title":"PLoS One"},{"key":"2021080205101042300_CIT0011","doi-asserted-by":"crossref","first-page":"e0137096","DOI":"10.1371\/journal.pone.0137096","article-title":"Association of CMV-specific T cell-mediated immunity with CMV DNAemia and development of CMV disease in HIV-1-infected individuals","volume":"10","author":"Aichelburg","year":"2015","journal-title":"PLoS One"},{"key":"2021080205101042300_CIT0012","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3343\/alm.2017.37.3.277","article-title":"Clinical usefulness of monitoring cytomegalovirus-specific immunity by quantiferon-CMV in pediatric allogeneic hematopoietic stem cell transplantation recipients","volume":"37","author":"Lee","year":"2017","journal-title":"Ann Lab Med"},{"key":"2021080205101042300_CIT0013","doi-asserted-by":"crossref","first-page":"e01040-17","DOI":"10.1128\/JCM.01040-17","article-title":"Monitoring of cytomegalovirus (CMV)-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON-CMV assay for management of posttransplant CMV infection","volume":"56","author":"Chiereghin","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2021080205101042300_CIT0014","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1172\/JCI200317470","article-title":"Mature CD8(+) T lymphocyte response to viral infection during fetal life","volume":"111","author":"Marchant","year":"2003","journal-title":"J Clin Invest"},{"key":"2021080205101042300_CIT0015","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.4049\/jimmunol.172.4.2256","article-title":"Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection","volume":"172","author":"Gibson","year":"2004","journal-title":"J Immunol"},{"key":"2021080205101042300_CIT0016","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/sji.12013","article-title":"Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children","volume":"77","author":"Lideh\u00e4ll","year":"2013","journal-title":"Scand J Immunol"},{"key":"2021080205101042300_CIT0017","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1203\/01.PDR.0000104150.85437.FE","article-title":"Cellular immune response of fetuses to cytomegalovirus","volume":"55","author":"Elbou Ould","year":"2004","journal-title":"Pediatr Res"},{"key":"2021080205101042300_CIT0018","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1128\/JVI.00052-07","article-title":"Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation","volume":"81","author":"Miles","year":"2007","journal-title":"J Virol"},{"key":"2021080205101042300_CIT0019","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/INF.0000000000001763","article-title":"Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management","volume":"36","author":"Luck","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"2021080205101042300_CIT0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N Engl J Med"},{"key":"2021080205101042300_CIT0021","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021080205101042300_CIT0022","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/00365513.2014.936679","article-title":"Diagnosis and prognosis of congenital CMV infection: a case report and review of the literature","volume":"244","author":"Lazzarotto","year":"2014","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"2021080205101042300_CIT0023","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1038\/cti.2014.3","article-title":"Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation","volume":"3","author":"Fern\u00e1ndez-Ruiz","year":"2014","journal-title":"Clin Transl Immunology"},{"key":"2021080205101042300_CIT0024","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(77)90782-6","article-title":"Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers","volume":"2","author":"Gehrz","year":"1977","journal-title":"Lancet"},{"key":"2021080205101042300_CIT0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/infdis\/148.6.953","article-title":"Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus","volume":"148","author":"Pass","year":"1983","journal-title":"J Infect Dis"},{"key":"2021080205101042300_CIT0026","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/infdis\/jiv071","article-title":"Functional exhaustion limits CD4+ and CD8+ T-cell responses to congenital cytomegalovirus infection","volume":"212","author":"Huygens","year":"2015","journal-title":"J Infect Dis"},{"key":"2021080205101042300_CIT0027","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10875-015-0139-3","article-title":"Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection","volume":"35","author":"Gibson","year":"2015","journal-title":"J Clin Immunol"},{"key":"2021080205101042300_CIT0028","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.4049\/jimmunol.172.5.3260","article-title":"Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children","volume":"172","author":"Tu","year":"2004","journal-title":"J Immunol"},{"key":"2021080205101042300_CIT0029","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/infdis\/jiz181","article-title":"Prospective assessment of cytomegalovirus immunity in high-risk donor-seropositive\/recipient-seronegative liver transplant recipients receiving either preemptive therapy or antiviral prophylaxis","volume":"220","author":"Limaye","year":"2019","journal-title":"J Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa704\/33524704\/ciaa704.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/3\/367\/39508461\/ciaa704.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/3\/367\/39508461\/ciaa704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T05:10:34Z","timestamp":1627881034000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/3\/367\/5854054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,6,5]]},"published-print":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa704","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2020,6,5]]}}}